Next Article in Journal
Gestational Diabetes and the Gut Microbiota: Fibre and Polyphenol Supplementation as a Therapeutic Strategy
Previous Article in Journal
LPS-Dephosphorylating Cobetia amphilecti Alkaline Phosphatase of PhoA Family Divergent from the Multiple Homologues of Cobetia spp.
Previous Article in Special Issue
Antibiotic Resistance of Bacillus cereus in Plant Foods and Edible Wild Mushrooms in a Province
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Rare Plasmid-Mediated AmpC Beta-Lactamase DHA-1 Located on Easy Mobilized IS26-Related Genetic Element Detected in Escherichia coli from Livestock and Food in Germany

by
Chiara Manfreda
1,2,
Annemarie Kaesbohrer
2,
Silvia Schmoger
2,
Tanja Skladnikiewicz-Ziemer
2,
Mirjam Grobbel
2 and
Alexandra Irrgang
2,*
1
Department of Food and Drugs, University of Parma, 43126 Parma, Italy
2
Department Biological Safety, German Federal Institute for Risk Assessment, 10589 Berlin, Germany
*
Author to whom correspondence should be addressed.
Microorganisms 2024, 12(3), 632; https://doi.org/10.3390/microorganisms12030632
Submission received: 7 February 2024 / Revised: 19 March 2024 / Accepted: 19 March 2024 / Published: 21 March 2024
(This article belongs to the Special Issue Antibiotic Resistance in Foodborne Bacteria)

Abstract

:
AmpC beta-lactamases cause resistance to third-generation cephalosporins, including beta-lactamase inhibitors. In Escherichia coli from the German food production chain, the majority of AmpC beta-lactamase activity can be attributed to plasmid-mediated CMY-2 or overproduction of chromosomal AmpC beta-lactamase, but occasionally other enzymes like DHA-1 are involved. This study investigated the prevalence of the AmpC beta-lactamase DHA-1 in ESBL/AmpC-producing E. coli (n = 4706) collected between 2016 and 2021 as part of a German antimicrobial resistance monitoring program along the food chain. Eight isolates (prevalence < 0.2%) were detected and further characterized by PFGE, transformation and conjugation experiments as well as short-read and long-read sequencing. All eight strains harbored blaDHA-1 together with qnrB4, sul1 and mph(A) resistance genes on an IS26 composite transposon on self-transferable IncFII or IncFIA/FIB/II plasmids. During laboratory experiments, activation of the translocatable unit of IS26-bound structures was observed. This was shown by the variability of plasmid sizes in original isolates, transconjugants or transferred plasmids, and correspondingly, duplications of resistance fragments were found in long-read sequencing. This activation could be artificial due to laboratory handling or naturally occurring. Nevertheless, DHA-1 is a rare AmpC beta-lactamase in livestock and food in Germany, and its dissemination will be monitored in the future.

1. Introduction

The increase in bacterial strains producing extended-spectrum beta-lactamases (ESBLs) and/or acquired AmpC beta-lactamases, which cause severe infections in humans, and their possible association with food or food-producing animals is of great concern to public health authorities [1,2].
Beta-lactamase production by Gram-negative bacteria, such as Enterobacterales, represents the main cause of beta-lactam resistance. Some of the beta-lactamases mediate resistance to third-generation cephalosporins, including oxyimino-cephalosporins (e.g., cefuroxime, cefotaxime, ceftriaxone, ceftazidime and cefepime), and are therefore referred to as ESBLs [3]. In contrast to AmpC beta-lactamases, ESBLs can often be inhibited by clavulanic acid or tazobactams.
Mobile elements, including conjugative plasmids, play a significant role in the transmission of ESBL enzymes in Enterobacterales, allowing rapid resistance dissemination. AmpC-mediated resistance in Escherichia coli can result either from constitutive overexpression of the chromosomal AmpC gene (due to mutations in the promoter/attenuator region) or from the acquisition of plasmid-mediated AmpC beta lactamases (pAmpC) [4].
There are different families of pAmpC: CMY-1 and -2, MIR, MOX, LAT, FOX, DHA, ACT, ACC and CFE [5]. All pAmpC enzymes belong to Ambler Class C, with CMY-2 being the most common in food-producing animals, particularly in broiler production [6]. Other pAmpCs are scarcely reported, one of which is DHA-1. This inducible AmpC beta-lactamase is closely related to the chromosomal AmpC gene of Morganella morganii, from which it is assumed to originate and successively migrate to plasmids [7,8,9,10]. It was first reported in Salmonella enteritidis, isolated from a clinical infection in Saudi Arabia in 1992 [11]. In principle, the Asian continent seems to have the highest prevalence of DHA-type enzymes in humans, associated mainly with Klebsiella pneumoniae [12,13]. Nevertheless, it has been globally detected in different Enterobacterales, such as Klebsiella spp., Salmonella spp. and E. coli [14,15,16,17,18,19,20,21,22].
In livestock animals, DHA-type enzymes were described in Listeria monocytogenes collected from cattle and their environment, including milking equipment at an Egyptian cattle farm in 2022, and in S. Heidelberg from cattle, pigs and turkey in the USA in 2009 [23,24]. Recent publications have also described the presence of the blaDHA-1 gene in E. coli and Citrobacter freundii in frozen chicken carcasses from Mozambique, Brazil and South Africa and several K. pneumoniae and one E. coli in chicken fecal samples from Malaysia [25,26]. Further, blaDHA-1 was detected in Enterobacterales, such as Proteus mirabilis, E. coli and K. pneuomoniae, collected from pig production in India and Korea [12,27]. Food of animal origin can also be considered a source of blaDHA-1 as it has been described in a number of publications in recent years, especially in Pseudomonas aeruginosa collected from bovine and ovine meat, raw milk and fishery products from Iran [28,29,30,31] but also in K. pneumoniae and E. coli strains isolated from shrimp in Germany, in E. coli isolated from beef products in South Africa and in K. pneumoniae isolated from ready-to-eat sandwiches in Algeria [32,33,34].
Although DHA-1-producing bacteria have been found in the food production chain, data on their prevalence in livestock and food is missing. The aim of this study was to assess the occurrence of blaDHA-1 in E. coli isolates collected as part of antimicrobial resistance (AMR) monitoring of the German food production chain and to characterize them genetically.

2. Materials and Methods

2.1. Sampling and Isolation of E. coli

For this study, ESBL/AmpC-producing E. coli isolates from the German antimicrobial resistance monitoring program for the years 2016–2021 were investigated. The AMR monitoring was conducted following technical specifications given by Commission Implementing Decision (CID) 2013/652/EU and CID 2020/1729/EU and complemented by additional national programs using the same methods [35,36]. The samples were taken from feces at primary production, caecum content at slaughter or food at retail by the federal states and investigated at the regional laboratories. Indicator E. coli samples were sent to the national reference laboratory for antimicrobial resistance (NRL-AR) at the German Federal Institute for Risk Assessment (BfR) and subjected to antimicrobial susceptibility testing. From the same samples, selective isolation of ESBL/AmpC-producing E. coli was conducted according to the protocol provided by the European Reference Laboratory for Antimicrobial Resistance (EURL-AR; https://www.eurl-ar.eu/protocols.aspx (accessed on 19 December 2023)). In brief, each sample was diluted 1:10 with buffered peptone water, homogenized and incubated overnight for 18–24 h at 37 °C. A 10 µL loop was streaked out on MacConkey agar supplemented with 1 μg/mL cefotaxime for 18–24 h at 37 °C. E. coli isolates were confirmed by MALDI-TOF (Bruker Daltonik GmbH, Leipzig, Germany).

2.2. Antimicrobial Susceptibility Testing

In the years 2014–2020, all E. coli isolates were tested for their susceptibility to 14 different antimicrobials by determination of the minimal inhibitory concentration (MIC) using broth microdilution with commercial plates (Thermo Fisher Scientific, Schwerte, Germany) following CID 2013/652/EU [35]. All isolates with resistance to cefotaxime and/or ceftazidime were tested on a second MIC panel for phenotypic characterization of the beta-lactamase (Thermo Fisher Scientific, Schwerte, Germany). Since 2021, commensal E. coli samples have been phenotypically characterized by MIC according to CID 2020/1729/EU with the antimicrobial panel EUVSEC3 (Thermo Fisher Scientific, Schwerte, Germany) [36]. Following this CID indicator, E. coli resistant to cefotaxime and/or ceftazidime, as well as selectively resistant to cefotaxime, were isolated and subjected to whole-genome sequencing (WGS). MIC values were interpreted using ECOFF values given in the CID or, when missing in the CID, defined by the European Food Safety Authority (EFSA). In this study, non-wild-type isolates with an MIC value above ECOFF are referred to as “resistant”. As antimicrobial panel and ECOFF values differ between CIDs, all blaDHA-1-positive isolates were tested with the new panel (EUVSEC3) and interpreted with the actual ECOFF values.

2.3. Molecular Analysis

All phenotypically ESBL/AmpC-suspicious isolates (n = 4706) between 2016 and 2020 were investigated by real-time PCR for the presence of blaCTX, blaTEM, blaSHV and blaCMY genes according to Roschanski et al. (2014) prior to this study [37]. Isolates with a MIC profile suspicious for AmpC production and blaCMY-negative by real-time PCR were investigated by PCR for the presence of DHA family-specific plasmid-mediated AmpC genes (blaDHA-1, blaDHA-2). PCR was also performed for ESBL-suspicious isolates for which no other ESBL genes were detected. In sum, 410 E. coli isolates were screened. The primers used for the amplification were DHA-F (5′-AACTTTCACAGGTGTGCTGGGT-3′) and DHA-R (5′- CCGTACGCATACTGGCTTTGC-3′), with an annealing temperature of 60 °C and an expected amplicon size of 405 bp [38]. Since 2021, all cefotaxime-resistant isolates have been investigated by WGS, including AMR gene detection with AMRFinder (please see below).
All blaDHA-1-positive isolates were characterized phylogenetically by XbaI pulsed-field gel electrophoresis (PFGE) using the PulseNet PFGE protocol (https://www.cdc.gov/pulsenet/pdf/ecoli-shigella-salmonella-pfge-protocol-508c.pdf; accessed on 19 December 2023). The localization of the blaDHA-1 gene in plasmids was determined by digestion with S1 nuclease with subsequent Southern blot hybridization using a blaDHA-1 probe [39].
From each isolate, plasmids were extracted using the Agencourt CosMCPrep Kit (Beckman Coulter, Krefeld, Germany) according to the manufacturer’s instructions. The transformation process was carried out using GeneHogs® E. coli strain as a competent cell and 0.1 cm disposable cuvettes in a MicroPulser electroporator (both from Bio-Rad, Feldkirchen, Germany) according to the manufacturer’s instructions. Cells were recovered in SOC medium for 1 h at 37 °C, and 100 µL was plated on LBA supplemented with 1 mg/L cefotaxime for 48 h at 37 °C. Up to 4 colonies were picked, and the transformation of DHA-1-harboring plasmid was confirmed by PCR as described above. The size of the transferred plasmid was determined by S1-PFGE. Further, plasmid replicon type was determined by PCR replicon typing using PBRT 2.0 (Diatheva, Fano, Italy). Transferability of the blaDHA-1-harboring plasmids was investigated by filter mating experiments at 37 °C with the original strains as well as the transformed cells as donors and the E. coli J53 strain as recipients [40].

2.4. Sequencing Analysis

WGS of the blaDHA-1-positive isolates was performed. Genomic DNA was isolated from overnight cultures using the PureLink® Genomic DNA Mini Kit (Thermo Fisher Scientific, Schwerte, Germany). For Illumina NextSeq short-read sequencing, libraries were prepared with the Nextera™XT DNA Library Preparation Kit or the Nextera™DNA Flex Library Preparation Kit (Illumina, San Diego, CA, USA) according to the manufacturer’s protocol. Raw reads were quality checked and processed using the AQUAMIS pipeline (https://gitlab.com/bfr_bioinformatics/AQUAMIS (accessed on 19 December 2023)) [41].
Long-read sequencing was performed using MinIon Mk1C with Rapid Barcoding Kit 96 (SQK-RBK110.96) and an R9.4.1 flow cell (ONT—Oxford Nanopore Technologies, Oxford, UK). Long-read data were processed by the MiLongA pipeline (https://gitlab.com/bfr_bioinformatics/milonga (accessed on 19 December 2023)), which included the hybrid assemblers Flye (2.9-b1768) and Unicycler (v0.4.8). For further analysis, Unicycler hybrid assemblies were mainly used. Assemblies were analyzed by our in-house pipeline Bakcharak (https://gitlab.com/bfr_bioinformatics/bakcharak (accessed on 19 December 2023)) with regard to multi-locus sequence typing (MLST), Clermont typing, AMR genes, plasmid typing or serotyping. Additionally, web-based tools of the Center for Genomic Epidemiology (http://www.genomicepidemiology.org (accessed on 18 December 2023)) were used for comparative analyses: MINTyper v.1.0 [42] with default settings for SNP analysis and cgMLSTFinder 1.2 version 1.0.1 [43,44]. Additionally, the chewieSnake pipeline (https://gitlab.com/bfr_bioinformatics/chewieSnake (accessed on 19 December 2023)) was used for core genome MLST (cgMLST) [45]. Annotation was carried out using RASTk on PATRIC (www.bv-brc.org (accessed on 19 December 2023)), and ISfinder was used for identification of mobile genetic elements (https://www-is.biotoul.fr (accessed on 19 December 2023)). BRIG (v.0.95) was used to display the mapping of reads against reference plasmids.
Raw short-read sequences were deposited at NCBI under BioProject accession number PRJNA995946 with SRA accession number SRR25318555-62, as were the complete blaDHA-1 plasmid sequences of 19-AB01500 (pEC19-AB01500 Genbank accession no. OR347004), 19-AB02469 (pEC19-AB02469 Genbank accession no. OR351271) and 21-AB01800 (pEC21-AB01800 Genbank acc. no. PP129611) as prototypes for the detected plasmids.

3. Results and Discussion

Between 2016 and 2021, a total of 4706 ESBL/AmpC-producing E. coli were detected within the German AMR monitoring program. According to the study criteria, 410 isolates from the years 2016–2020 were screened by PCR for the presence of blaDHA, whereas in 2021, ESBL/AmpC determination was conducted by WGS. In total, eight blaDHA-1-producing E. coli were detected in livestock and food in Germany. In particular, four were obtained from pig production (primary production or at slaughter), two were obtained from freshwater fish (Pangasianodon sp.; presumably both imported), one was collected from a calf at slaughter and one was recovered from wildlife (wild goose feces).
According to the high number of investigated ESBL/AmpC-producing isolates in total within the AMR monitoring program (n = 4706), blaDHA-1 can be considered a rare AmpC genotype in the German food production chain with a prevalence below 0.2%. This is comparable to other European countries, where the prevalence of blaDHA-1 in food-producing animals and meat was between 0% and 1% in 2021 in the countries reporting WGS data [46]. Although DHA-1-producing bacteria can be found in livestock and food, the food chain does not seem to be the main reservoir. Most reports can be found from human infections, with an emphasis on Klebsiella spp. in Asian countries [12,13].
Among the eight investigated isolates in this study, five different MIC profiles were found. In general, the isolates were resistant to six to seven different antimicrobial classes. Thus, all were multidrug resistant, exhibiting resistance to ampicillin, azithromycin, ciprofloxacin, cefotaxime and ceftazidime. Moreover, the majority of isolates (6/8) showed potential pAmpC presence, while the other isolates (2/8) were classified as a combination suspicious for ESBL/pAmpC (Table 1). This was consistent with the genotypes, as these two isolates harbored additional blaCTX-M genes.
The phylogenetic relationship of the isolates was investigated by PFGE and SNP analysis (Supplementary Table S1) using Illumina raw reads and cgMLST using assembled genomes. All three methods revealed a non-clonal phylogenetic relationship. The single linkage trees of SNP analysis and cgMLST (Figure 1) were highly similar. This is in concordance with the high diversity of the five different phylogenetic groups of the isolates, the different matrices from which the isolates originate and the long period of 5 years in which these eight positive samples were taken. An epidemiological link could have been possible for isolates 19-AB01177, 19-AB01178 and 19-AB01179 as the samples were taken at the same time from the same region, but it was not observed during the analysis.
Because no clonal relationship was detected, a spread of blaDHA-1 via plasmids was hypothesized. The blaDHA-1-harboring plasmid was self-transferable by conjugation, and the gene was transferable by transformation. Based on PBRT replicon typing, the gene was located on IncFII or IncFIA/FIB/FII plasmids (Table 2). Determination of the plasmid size and its characteristics proved to be difficult by molecular methods. S1-PFGE as well as subsequent Southern blot hybridization revealed no clear plasmid determination for three of the eight isolates. Transformation of the blaDHA-1-harboring plasmids also revealed inconsistent results for four isolates (Table 2). Different transferred plasmids from the same original isolates showed different sizes in S1-PFGE, which also did not correspond to the sizes of plasmids detected in the original isolates. Similar problems were found with transconjugation.
There are different possible explanations for the inconclusive results. The first option is that there was more than one copy of the blaDHA-1 gene present on different plasmids. The second option is that the blaDHA-1 gene is part of a literally mobile genetic element that was mobilized during laboratory handling, leading to artificially altered results. Comprehensive genomic investigations with short- and long-read sequencing approaches were conducted to obtain a closer insight into the genetic structure of blaDHA-1 plasmids.
Assemblies of Illumina short-read sequences revealed a 15,141–15,143 bp long circular fragment, which was flanked by 91 bp inverted repeats and harbored resistance genes against cephalosporins (blaDHA-1), fluoroquinolones (qnrB4), sulfonamides (sul1) and macrolides (mph(A)). Hybrid assemblies of long- and short-read sequences could extend this to 18,322–19,970 bp long fragments. There, the fragment found in short-read sequences was flanked by two IS26 element transposases, forming a composite transposon (Figure 2). This was associated with an additional incomplete class I integrase, the trimethoprim resistance gene dfrA17, the truncated aminoglycoside resistance gene aadA5 and another IS26 transposase, except for isolate 19-AB02469 (Figure 2). This structure was found to have very high similarities to the IncFII plasmid p133355_SW_C4_Cam-1 in Citrobacter amalonaticus (NZ_CP041363) from humans and pIV_IncFII_DHA in E. coli (MN537908) from an infected dog [47,48]. Mapping of the Illumina raw reads against NZ_CP041363 (Figure 3) and MN537908 also revealed high similarities to the plasmid backbone. Inversion of the int1-dfrA17-aadA5 fragment was found in three of the isolates confirmed by PCR. Closed plasmids were obtained by long-read sequencing for only three isolates. Two of these plasmids showed a divergent flanking structure of the blaDHA-1-harboring fragment (Figure 2). The high density of mobile genetic elements, especially repeated IS26 transposases in the region, hampered complete plasmid assembly for the remaining isolates.
Further, the mappings showed that the blaDHA-1-harboring fragment had a higher coverage by the reads than the plasmid average, suggesting that more than one copy might be possible. Additionally, inverted repeats flanking IS26 transposase were at least found in three further positions on the plasmid of 19-AB02469, where long-read sequencing revealed a complete 160 kb long plasmid sequence. This suggested that insertion and excision events of IS26 elements had taken place in the past and that mobilization during laboratory work was likely. For confirmation of this hypothesis, different transformed cells in the samples were investigated by long-read sequencing. With this, we could resolve some of the issues by taking into account both assembly strategies (Flye and Unicycler). Although Flye tends to duplicate small plasmids, it mostly showed duplications of resistance genes when the transferred plasmid also showed a bigger size in S1-PFGE compared to other transferred plasmids of the same transformation experiments and the same original strain [49]. The copied resistance fragment is supported by much higher coverage values compared to the rest of the plasmid. Additionally, for 19-AB00708 and 19-AB01179, some blaDHA-1-transformed plasmids showed a two- or three-times larger size than that estimated by the sequencing data. Therefore, in addition to blaDHA-1 fragment duplications via lab handling, complete plasmid copying also took place.
As it is not possible to determine the physiological sizes and structure of the blaDHA-1 plasmids, except for 19-AB01500 and 19-AB02469, the plasmid sizes given in Table 2 should be understood as the minimum plasmid sizes. These result from the sum of the blaDHA-1 fragment and the size of the plasmid backbone.
We hypothesize that plasmid size variabilities were artificial and due to lab handling. Although it could theoretically also occur in bacterial cells in the natural habitat, the low prevalence of ESBL/AmpC-producing E. coli in the German food chain, as well as the reported highly similar plasmids in Enterobacterales from humans and animals from different countries and different years, does not support a naturally highly active mobile genetic element [47,48]. The structure found in animals with resistance islands harboring ∆aadA5, dfrA17, qnrB4, blaDHA-1 and mph(A) seems to be stable but is not frequently reported in humans. Further, most of the reported blaDHA-1-producing bacteria were obtained from human infections associated with Klebsiella sp. [50]. However, as the ESBL/AmpC monitoring in livestock and food is limited to E. coli, we cannot estimate the spread of DHA-1 in other Enterobacterales and the associated genetic structure. However, most blaDHA-1 plasmids are self-transmissible, and if there was a spread of DHA-1-producing Enterobacterales, a higher prevalence in E. coli would also be expected as long as the related plasmids are able to replicate in E. coli. In the reported Enterobacterales from humans, a variety of plasmids (IncF, IncHI2, IncR, IncL/M and IncA/C2) of different sizes and co-resistance genes have been reported [14,18,48,51]. In all species and matrices, blaDHA-1 is associated with qnrB4. Typically, further ESBL genes are detected in human samples, whereas only two of the isolates in this study harbored additional blaCTX-M genes [9,15,16,18,50].
A big driver for resistance spread is IS26 [52]. IS26 transposons can be complex, and several transposons can overlap. Transition of IS26 with incorporated (resistance) genes in conservative mode includes the formation of translocatable units (TU), and it is more efficient when another IS26 is recognized and insertion takes place next to it [53]. The formation of such cointegrates was observed in this study. The excision of TUs leaves an IS26 behind. This explains the high density of IS26 all over the blaDHA-1 plasmids [54]. As IS26 is located in different orientations, there might be an overlap of IS26-bound structures, as shown for Tn1696-related transposons in IncHI2 plasmids [55].

4. Conclusions

BlaDHA-1 is prevalent but rare in livestock and food in Germany. Although the gene was located in self-transferable plasmids and in active IS26-bounded structures, the spread of the gene seems to be limited. Ecological niches for related plasmids might be covered by other ESBL/pAmpC-gene-harboring plasmids of E. coli, or the spread of blaDHA-1 takes place in other Enterobacterales than those that were monitored. As dissemination can change over time due to varying environmental conditions, trade networks and food production systems, ongoing monitoring of ESBL/pAmpC-producing Enterobacterales is needed to assess the potential of consumers being exposed to multidrug-resistant bacteria. Situations where such resistance genes find their niche and spread within a production chain need to be detected early. Although resistance genes themselves are not pathogenic, their spread to potentially pathogenic species can limit the therapeutic options in cases of infection.
This study shows that molecular methods or sequencing analyses alone are not enough to reveal the genetic organization of some bacterial strains and their resistance determinants, and a combination of different approaches is required to evaluate the potential for increasing or emerging public health risks.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/microorganisms12030632/s1, Table S1: SNP analysis of DHA-1-producing E. coli from the food chain in Germany.

Author Contributions

Conceptualization, A.I. and A.K.; methodology, A.I. and M.G.; investigation, C.M., A.I., T.S.-Z. and S.S.; resources, A.I. and M.G.; data curation, C.M. and A.I.; writing—original draft preparation, C.M. and A.I.; writing—review and editing, M.G., S.S. and A.K.; visualization, C.M. and A.I.; supervision, A.I. and A.K.; project administration, A.I. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding. The study was funded by the German Institute for Risk Assessment under project 43-001.

Data Availability Statement

Raw sequencing data and complete reference plasmids are deposited at NCBI (see Section 2.3).

Acknowledgments

The authors gratefully acknowledge the support of the regional laboratories and authorities in collecting the samples and providing the isolates in the framework of the antimicrobial resistance monitoring program. We thank the German NRL-AR team for excellent technical assistance, especially Silke Jahn and Janina Malekzadah. Thanks to Ulrike Binsker for reading the manuscript.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. European Food Safety Authority. Scientific Opinion on the public health risks of bacterial strains producing extended-spectrum β-lactamases and/or AmpC β-lactamases in food and food-producing animals. EFSA J. 2011, 9, 2322. [Google Scholar] [CrossRef]
  2. European Centre for Disease Prevention and Control. Systematic Review of the Effectiveness of Infection Control Measures to Prevent the Transmission of Carbapenemase-Producing Enterobacteriaceae through Cross-Border Transfer of Patients; ECDC: Stockholm, Sweden, 2014. Available online: https://data.europa.eu/doi/10.2900/418192 (accessed on 30 January 2024).
  3. Livermore, D. β -Lactamases- the threat renews. Curr. Protein Pept. Sci. 2009, 10, 397–400. [Google Scholar] [CrossRef] [PubMed]
  4. Peter-Getzlaff, S.; Polsfuss, S.; Poledica, M.; Hombach, M.; Giger, J.; Böttger, E.C.; Zbinden, R.; Bloemberg, G.V. Detection of AmpC beta-lactamase in Escherichia coli: Comparison of three phenotypic confirmation assays and genetic analysis. J. Clin. Microbiol. 2011, 49, 2924–2932. [Google Scholar] [CrossRef] [PubMed]
  5. Jacoby, G.A. AmpC beta-lactamases. Clin. Microbiol. Rev. 2009, 22, 161–182. [Google Scholar] [CrossRef] [PubMed]
  6. Bush, K.; Jacoby, G.A. Updated Functional Classification of β-Lactamases. Antimicrob. Agents Chemother. 2010, 54, 969–976. [Google Scholar] [CrossRef] [PubMed]
  7. Reisbig, M.D.; Hanson, N.D. The ACT-1 plasmid-encoded AmpC beta-lactamase is inducible: Detection in a complex beta-lactamase background. J. Antimicrob. Chemother. 2002, 49, 557–560. [Google Scholar] [CrossRef] [PubMed]
  8. Rayamajhi, N.; Jung, B.Y.; Cha, S.B.; Shin, M.K.; Kim, A.; Kang, M.S.; Lee, K.M.; Yoo, H.S. Antibiotic resistance patterns and detection of blaDHA-1 in Salmonella species isolates from chicken farms in South Korea. Appl. Environ. Microbiol. 2010, 76, 4760–4764. [Google Scholar] [CrossRef] [PubMed]
  9. Pai, H.; Kang, C.-I.; Byeon, J.-H.; Lee, K.-D.; Park, W.B.; Kim, H.-B.; Kim, E.-C.; Oh, M.; Choe, K.-W. Epidemiology and clinical features of bloodstream infections caused by AmpC-type-β-lactamase-producing Klebsiella pneumoniae. Antimicrob. Agents Chemother. 2004, 48, 3720–3728. [Google Scholar] [CrossRef] [PubMed]
  10. Barnaud, G.; Arlet, G.; Verdet, C.; Gaillot, O.; Lagrange, P.H.; Philippon, A. Salmonella enteritidis: AmpC plasmid-mediated inducible β-Lactamase (DHA-1) with an ampR gene from Morganella morganii. Antimicrob. Agents Chemother. 1998, 42, 2352–2358. [Google Scholar] [CrossRef]
  11. Gaillot, O.; Clément, C.; Simonet, M.; Philippon, A. Novel transferable beta-lactam resistance with cephalosporinase characteristics in Salmonella enteritidis. J. Antimicrob. Chemother. 1997, 39, 85–87. [Google Scholar] [CrossRef]
  12. Rayamajhi, N.; Kang, S.; Lee, D.; Kang, M.; Lee, S.; Park, K.; Lee, H.; Yoo, H. Characterization of TEM-, SHV- and AmpC-type β-lactamases from cephalosporin-resistant Enterobacteriaceae isolated from swine. Int. J. Food Microbiol. 2008, 124, 183–187. [Google Scholar] [CrossRef] [PubMed]
  13. Lee, K.; Lee, M.; Shin, J.H.; Lee, M.H.; Kang, S.H.; Park, A.J.; Yong, D.; Chong, Y. Prevalence of plasmid-mediated AmpC β -lactamases in Escherichia coli and Klebsiella pneumoniae in Korea. Microb. Drug Resist. 2006, 12, 44–49. [Google Scholar] [CrossRef] [PubMed]
  14. Ribeiro, T.G.; Novais, Â.; Rodrigues, C.; Nascimento, R.; Freitas, F.; Machado, E.; Peixe, L. Dynamics of clonal and plasmid backgrounds of Enterobacteriaceae producing acquired AmpC in Portuguese clinical settings over time. Int. J. Antimicrob. Agents 2019, 53, 650–656. [Google Scholar] [CrossRef] [PubMed]
  15. Kis, Z.; Tóth, Á.; Jánvári, L.; Damjanova, I. Countrywide dissemination of a DHA-1-type plasmid-mediated AmpC β-lactamase-producing Klebsiella pneumoniae ST11 international high-risk clone in Hungary, 2009–2013. J. Med. Microbiol. 2016, 65, 1020–1027. [Google Scholar] [CrossRef] [PubMed]
  16. Freitas, F.; Machado, E.; Ribeiro, T.G.; Novais, Â.; Peixe, L. Long-term dissemination of acquired AmpC β-lactamases among Klebsiella spp. and Escherichia coli in Portuguese clinical settings. Eur. J. Clin. Microbiol. Infect. Dis. 2014, 33, 551–558. [Google Scholar] [CrossRef]
  17. Empel, J.; Hrabák, J.; Kozińska, A.; Bergerová, T.; Urbášková, P.; Kern-Zdanowicz, I.; Gniadkowski, M. DHA-1-producing Klebsiella pneumoniae in a teaching hospital in the Czech Republic. Microb. Drug Resist. 2010, 16, 291–295. [Google Scholar] [CrossRef] [PubMed]
  18. Diestra, K.; Miró, E.; Martí, C.; Navarro, D.; Cuquet, J.; Coll, P.; Navarro, F. Multiclonal epidemic of Klebsiella pneumoniae isolates producing DHA-1 in a Spanish hospital. Clin. Microbiol. Infect. 2011, 17, 1032–1036. [Google Scholar] [CrossRef] [PubMed]
  19. Estaleva, C.E.L.; Zimba, T.F.; Sekyere, J.O.; Govinden, U.; Chenia, H.Y.; Simonsen, G.S.; Haldorsen, B.; Essack, S.Y.; Sundsfjord, A. High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique. BMC Infect. Dis. 2021, 21, 16. [Google Scholar] [CrossRef] [PubMed]
  20. Liebana, E.; Batchelor, M.; Clifton-Hadley, F.A.; Davies, R.H.; Hopkins, K.L.; Threlfall, E.J. First report of Salmonella isolates with the DHA-1 AmpC beta-lactamase in the United Kingdom. Antimicrob. Agents Chemother. 2004, 48, 4492. [Google Scholar] [CrossRef]
  21. Moland, E.S.; Black, J.A.; Ourada, J.; Reisbig, M.D.; Hanson, N.D.; Thomson, K.S. Occurrence of newer β-Lactamases in Klebsiella pneumoniae isolates from 24 U.S. hospitals. Antimicrob. Agents Chemother. 2002, 46, 3837–3842. [Google Scholar] [CrossRef]
  22. Alvarez, M.; Tran, J.H.; Chow, N.; Jacoby, G.A. Epidemiology of conjugative plasmid-mediated AmpC β-Lactamases in the United States. Antimicrob. Agents Chemother. 2004, 48, 533–537. [Google Scholar] [CrossRef] [PubMed]
  23. Lynne, A.M.; Kaldhone, P.; David, D.; White, D.G.; Foley, S.L. Characterization of antimicrobial resistance in Salmonella enterica serotype Heidelberg isolated from food animals. Foodborne Pathog. Dis. 2009, 6, 207–215. [Google Scholar] [CrossRef] [PubMed]
  24. Elsayed, M.M.; Elkenany, R.M.; Zakaria, A.I.; Badawy, B.M. Epidemiological study on Listeria monocytogenes in Egyptian dairy cattle farms’ insights into genetic diversity of multi-antibiotic-resistant strains by ERIC-PCR. Environ. Sci. Pollut. Res. 2022, 29, 54359–54377. [Google Scholar] [CrossRef] [PubMed]
  25. Tan, H.-S.; Pan, Y.; Agustie, H.; Loh, H.-S.; Rayamajhi, N.; Fang, C.-M. Characterisation of ESBL/AmpC-Producing Enterobacteriaceae isolated from poultry farms in Peninsular Malaysia. Lett. Appl. Microbiol. 2023, 76, ovac044. [Google Scholar] [CrossRef]
  26. Faife, S.L.; Zimba, T.; Sekyere, J.O.; Govinden, U.; Chenia, H.Y.; Simonsen, G.S.; Sundsfjord, A.; Essack, S.Y. β-lactam and fluoroquinolone resistance in Enterobacteriaceae from imported and locally-produced chicken in Mozambique. J. Infect. Dev. Ctries. 2020, 14, 471–478. [Google Scholar] [CrossRef] [PubMed]
  27. Chinnam, B.K.; Nelapati, S.; Tumati, S.R.; Bobbadi, S.; Chaitanya Peddada, V.; Bodempudi, B. Detection of β-lactamase–producing Proteus mirabilis strains of animal origin in Andhra Pradesh, India and their genetic diversity. J. Food Prot. 2021, 84, 1374–1379. [Google Scholar] [CrossRef] [PubMed]
  28. Rezaloo, M.; Motalebi, A.; Mashak, Z.; Anvar, A. Prevalence, antimicrobial resistance, and molecular description of Pseudomonas aeruginosa isolated from meat and meat products. J. Food Qual. 2022, 2022, 9899338. [Google Scholar] [CrossRef]
  29. Poursina, S.; Ahmadi, M.; Fazeli, F.; Ariaii, P. Assessment of virulence factors and antimicrobial resistance among the Pseudomonas aeruginosa strains isolated from animal meat and carcass samples. Vet. Med. Sci. 2023, 9, 315–325. [Google Scholar] [CrossRef] [PubMed]
  30. Dehkordi, S.M.H.; Anvar, S.A.; Rahimi, E.; Ahari, H.; Ataee, M. Prevalence, phenotypic and genotypic diversity, antibiotic resistance, and frequency of virulence genes in Pseudomonas aeruginosa isolated from shrimps. Aquacult Int. 2022, 30, 131–156. [Google Scholar] [CrossRef]
  31. Dehkordi, S.M.H.; Anvar, S.A.; Rahimi, E.; Ahari, H.; Ataee, M. Molecular investigation of prevalence, phenotypic and genotypic diversity, antibiotic resistance, frequency of virulence genes and genome sequencing in Pseudomonas aeruginosa strains isolated from lobster. Int. J. Food Microbiol. 2022, 382, 109901. [Google Scholar] [CrossRef]
  32. Matloko, K.; Fri, J.; Ateba, T.P.; Molale-Tom, L.G.; Ateba, C.N. Evidence of potentially unrelated AmpC beta-lactamase producing Enterobacteriaceae from cattle, cattle products and hospital environments commonly harboring the blaACC resistance determinant. PLoS ONE 2021, 16, e0253647. [Google Scholar] [CrossRef] [PubMed]
  33. Yaici, L.; Haenni, M.; Métayer, V.; Saras, E.; Mesbah Zekar, F.; Ayad, M.; Touati, A.; Madec, J.-Y. Spread of ESBL/AmpC-producing Escherichia coli and Klebsiella pneumoniae in the community through ready-to-eat sandwiches in Algeria. Int. J. Food Microbiol. 2017, 245, 66–72. [Google Scholar] [CrossRef] [PubMed]
  34. Vu, T.T.T.; Alter, T.; Roesler, U.; Roschanski, N.; Huehn, S. Investigation of extended-spectrum and AmpC β-lactamase–producing Enterobacteriaceae from retail seafood in Berlin, Germany. J. Food Prot. 2018, 81, 1079–1086. [Google Scholar] [CrossRef]
  35. 2013/652/EU: Commission Implementing Decision of 12 November 2013 on the Monitoring and Reporting of Antimicrobial Resistance in Zoonotic and Commensal Bacteria. Available online: http://data.europa.eu/eli/dec_impl/2013/652/o (accessed on 29 January 2024).
  36. 2020/1729/EU: Commission Implementing Decision (EU) 2020/1729 of 17 November 2020 on the Monitoring and Reporting of Antimicrobial Resistance in Zoonotic and Commensal Bacteria and Repealing Implementing Decision 2013/652/EU. Available online: http://data.europa.eu/eli/dec_impl/2020/1729/o (accessed on 29 January 2024).
  37. Roschanski, N.; Fischer, J.; Guerra, B.; Roesler, U. Development of a multiplex Real-Time PCR for the rapid detection of the predominant beta-lactamase genes CTX-M, SHV, TEM and CIT-Type AmpCs in Enterobacteriaceae. PLoS ONE 2014, 9, e100956. [Google Scholar] [CrossRef] [PubMed]
  38. Pérez-Pérez, F.J.; Hanson, N.D. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 2002, 40, 2153–2162. [Google Scholar] [CrossRef] [PubMed]
  39. Rodríguez, I.; Barownick, W.; Helmuth, R.; Mendoza, M.C.; Rodicio, M.R.; Schroeter, A.; Guerra, B. Extended-spectrum ß-lactamases and AmpC ß-lactamases in ceftiofur-resistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003–2007. J. Antimicrob. Chemother. 2009, 64, 301–309. [Google Scholar] [CrossRef]
  40. Hammerl, J.A.; Klein, I.; Lanka, E.; Appel, B.; Hertwig, S. Genetic and functional properties of the self-transmissible Yersinia enterocolitica plasmid pYE854, which mobilizes the virulence plasmid pYV. J. Bacteriol. 2008, 190, 991–1010. [Google Scholar] [CrossRef]
  41. Deneke, C.; Brendebach, H.; Uelze, L.; Borowiak, M.; Malorny, B.; Tausch, S.H. Species-specific quality control, assembly and contamination detection in microbial isolate sequences with AQUAMIS. Genes 2021, 12, 644. [Google Scholar] [CrossRef] [PubMed]
  42. Hallgren, M.B.; Overballe-Petersen, S.; Lund, O.; Hasman, H.; Clausen, P.T.L.C. MINTyper: An outbreak-detection method for accurate and rapid SNP typing of clonal clusters with noisy long reads. Biol. Methods Protoc. 2021, 6, bpab008. [Google Scholar] [CrossRef]
  43. Zhou, Z.; Alikhan, N.-F.; Mohamed, K.; Fan, Y.; Achtman, M. The EnteroBase user’s guide, with case studies on Salmonella transmissions, Yersinia pestis phylogeny, and Escherichia core genomic diversity. Genome Res. 2020, 30, 138–152. [Google Scholar] [CrossRef]
  44. Clausen, P.T.L.C.; Aarestrup, F.M.; Lund, O. Rapid and precise alignment of raw reads against redundant databases with KMA. BMC Bioinform. 2018, 19, 307. [Google Scholar] [CrossRef] [PubMed]
  45. Deneke, C.; Uelze, L.; Brendebach, H.; Tausch, S.H.; Malorny, B. Decentralized investigation of bacterial outbreaks based on hashed cgMLST. Front. Microbiol. 2021, 12, 649517. [Google Scholar] [CrossRef] [PubMed]
  46. European Food Safety Authority; European Centre for Disease Prevention and Control. The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2020/2021. EFSA J. 2023, 21, e07867. [Google Scholar] [CrossRef]
  47. Mattioni Marchetti, V.; Bitar, I.; Mercato, A.; Nucleo, E.; Marchesini, F.; Mancinelli, M.; Prati, P.; Scarsi, G.S.; Hrabak, J.; Pagani, L.; et al. Deadly puppy infection caused by an MDR Escherichia coli O39 blaCTX–M–15, blaCMY–2, blaDHA–1, and aac(6)-Ib-cr positive in a breeding kennel in Central Italy. Front. Microbiol. 2020, 11, e00584. [Google Scholar] [CrossRef] [PubMed]
  48. Clément, M.; Keller, P.M.; Bernasconi, O.J.; Stirnimann, G.; Frey, P.M.; Bloemberg, G.V.; Sendi, P.; Endimiani, A. First clinical case of in vivo acquisition of DHA-1 plasmid-mediated AmpC in a Salmonella enterica subsp. enterica isolate. Antimicrob. Agents Chemother. 2019, 63, e00992-19. [Google Scholar] [CrossRef] [PubMed]
  49. Juraschek, K.; Borowiak, M.; Tausch, S.H.; Malorny, B.; Käsbohrer, A.; Otani, S.; Schwarz, S.; Meemken, D.; Deneke, C.; Hammerl, J.A. Outcome of different sequencing and assembly approaches on the detection of plasmids and localization of antimicrobial resistance genes in commensal Escherichia coli. Microorganisms 2021, 9, 598. [Google Scholar] [CrossRef] [PubMed]
  50. Hennequin, C.; Ravet, V.; Robin, F. Plasmids carrying DHA-1 β-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 2018, 37, 1197–1209. [Google Scholar] [CrossRef] [PubMed]
  51. Mahrouki, S.; Chihi, H.; Bourouis, A.; Ayari, K.; Ferjani, M.; Moussa, M.B.; Belhadj, O. Nosocomial dissemination of plasmids carrying blaTEM-24, blaDHA-1, aac(6’)-Ib-cr, and qnrA6 in Providencia spp. strains isolated from a Tunisian hospital. Diagn. Microbiol. Infect. Dis. 2015, 81, 50–52. [Google Scholar] [CrossRef]
  52. Harmer, C.J.; Hall, R.M. IS 26 -mediated formation of transposons carrying antibiotic resistance genes. mSphere 2016, 1, e00038-16. [Google Scholar] [CrossRef]
  53. Harmer, C.J.; Moran, R.A.; Hall, R.M. Movement of IS 26-associated antibiotic resistance genes occurs via a translocatable unit that includes a single IS26 and preferentially inserts adjacent to another IS26. mBio 2014, 5, e01801-14. [Google Scholar] [CrossRef]
  54. Harmer, C.J.; Hall, R.M. IS26-mediated precise excision of the IS26-aphA1a translocatable unit. mBio 2015, 6, e01866-15. [Google Scholar] [CrossRef]
  55. Cain, A.K.; Liu, X.; Djordjevic, S.P.; Hall, R.M. Transposons related to Tn 1696 in IncHI2 plasmids in multiply antibiotic resistant Salmonella enterica serovar Typhimurium from Australian animals. Microb. Drug Resist. 2010, 16, 197–202. [Google Scholar] [CrossRef]
Figure 1. Phylogenetic relationship of DHA-1-producing E. coli. Single linkage tree based on cgMLST analysis. The numbers on the branches indicate the number of allele differences.
Figure 1. Phylogenetic relationship of DHA-1-producing E. coli. Single linkage tree based on cgMLST analysis. The numbers on the branches indicate the number of allele differences.
Microorganisms 12 00632 g001
Figure 2. Genetic organization of the blaDHA-1 region. The blaDHA-1 gene is located on an IS26 composite transposon with the same structure in all isolates, except for 19-AB01500, in which additional resistances were incorporated. Flanking sequences of the IS26 composite transposon showed variabilities. The same colors in the boxes indicate the same genetic structures. Orientation of the gene fragments according to the position under (−) or above (+) the line is indicated by an arrow. The illustration is schematic and not to scale.
Figure 2. Genetic organization of the blaDHA-1 region. The blaDHA-1 gene is located on an IS26 composite transposon with the same structure in all isolates, except for 19-AB01500, in which additional resistances were incorporated. Flanking sequences of the IS26 composite transposon showed variabilities. The same colors in the boxes indicate the same genetic structures. Orientation of the gene fragments according to the position under (−) or above (+) the line is indicated by an arrow. The illustration is schematic and not to scale.
Microorganisms 12 00632 g002
Figure 3. Mapping of blaDHA-1-harboring plasmids in livestock and food in Germany against IncFII plasmid p133355_SW_C4_Cam-1 in Citrobacter amalonaticus (NZ_CP041363); genes with an asterisk are truncated or incomplete in the reference.
Figure 3. Mapping of blaDHA-1-harboring plasmids in livestock and food in Germany against IncFII plasmid p133355_SW_C4_Cam-1 in Citrobacter amalonaticus (NZ_CP041363); genes with an asterisk are truncated or incomplete in the reference.
Microorganisms 12 00632 g003
Table 1. Isolate characteristics of DHA-1-producing E. coli from the food production chain in Germany 2016–2021.
Table 1. Isolate characteristics of DHA-1-producing E. coli from the food production chain in Germany 2016–2021.
Isolate IDMatrixResistance Profile 1
[Beta-Lactam Phenotype 2]
Phylogenetic GroupMLSTResistance Genes 3
17-AB00899Calves, fecesAMP, AZI, CIP, FOT, NAL, TAZ, TET, TMP [AmpC]B1446blaDHA-1; dfrA17; mph(A); qnrB4; sul1; tet(A); tet(B)
19-AB00708Fattening pig,
feces
AMP, AZI, CIP, FOT, NAL, TAZ, TET, TMP [AmpC]C23blaDHA-1; dfrA17; mph(A); qnrB4; sul1; tet(A)
19-AB01177Fattening pig,
feces
AMP, AZI, CIP, FOT, NAL, SMX, TAZ, TET, TMP
[AmpC]
C369blaDHA-1; blaTEM-1; dfrA1; dfrA17; mph(A); qnrB4; sul1; sul2; tet(A)
19-AB01178Fattening pig,
feces
AMP, AZI, CIP, FOT, NAL, SMX, TAZ, TET, TMP [AmpC]E118aadA1; aph(3’)-Ia; blaDHA-1; blaTEM-34; dfrA1; dfrA17; emrD; mph(A); qnrB4; sat2; sul1; sul2; tet(B)
19-AB01179Fattening pig, fecesAMP, AZI, CIP, FOT, NAL, SMX, TAZ, TET, TMP [AmpC]C5271aadA1; aph(3’’)-Ib; aph(6)-Id; blaDHA-1, blaTEM-1; dfrA1; dfrA17; mph(A); qnrB4; sul1; sul2; tet(A)
19-AB01500Freshwater fishAMP, AZI, CIP, FOT, NAL, SMX, TAZ, TET, TMP [ESBL/AmpC]D69aph(3’’)-Ib; aph(6)-Id; blaCTX-M-27; blaDHA-1; blaTEM-1; cyaA_S352T; dfrA14; dfrA17; erm(B) *; gyrA_S83L; mdtM; mph(A); parE_D476N; qnrB4; sul1; sul2; tet(B) *
19-AB02469Wild goose,
feces
AMP, AZI, CIP, FOT, NAL, SMX, TAZ, TET [ESBL/AmpC]B2131aph(3’’)-Ib; aph(6)-Id; blaCTX-M-15; blaDHA-1; gyrA_D87N; gyrA_S83L; mph(A); parC_E84V; parC_S80I; parE_I529L; ptsI_V25I; qnrB4; sul1; sul2, tet(A); uhpT_E350Q
21-AB01800Freshwater fishAMP, AZI, CIP, FOT, SMX, TAZ, TMP [AmpC]B13570blaDHA-1; blaTEM-1; dfrA17; mph(A); qnrB4; sul1
1 Resistance profile is based on MIC data from the first panel. 2 Beta-lactam phenotype was determined by the MIC data of the second panel. 3 AMR genes obtained by WGS; genes with less than 100% identity to reference (*) were only listed when there was a corresponding phenotype, except for multidrug-resistant transporters (<100% identity not included). Abbreviations: AMP: ampicillin; AZI: azithromycin; CIP: ciprofloxacin; FOT: cefotaxime; NAL: nalidixic acid; TAZ: ceftazidime; SMX: sulfamethoxazole; TET: tetracycline; TMP: trimethoprim.
Table 2. Characterization of blaDHA-1-harboring plasmids.
Table 2. Characterization of blaDHA-1-harboring plasmids.
IsolatePlasmid Size (in kb)Incompatibility GroupConjugative
PFGE,
Transformed Plasmid
WGS 1
17-AB0089992/7483.5 FIIyes
19-AB00708210/19382FIIyes
19-AB011778777FIIyes
19-AB011787582FIIyes
19-AB01179141/178/88/14878.5FIIyes
19-AB01500141149FII, FIA, FIByes
19-AB02469152160FII, FIA, FIByes
21-AB0180058/11063.5FIIyes
1 Minimum plasmid size, obtained from Unicycler assemblies.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Manfreda, C.; Kaesbohrer, A.; Schmoger, S.; Skladnikiewicz-Ziemer, T.; Grobbel, M.; Irrgang, A. Rare Plasmid-Mediated AmpC Beta-Lactamase DHA-1 Located on Easy Mobilized IS26-Related Genetic Element Detected in Escherichia coli from Livestock and Food in Germany. Microorganisms 2024, 12, 632. https://doi.org/10.3390/microorganisms12030632

AMA Style

Manfreda C, Kaesbohrer A, Schmoger S, Skladnikiewicz-Ziemer T, Grobbel M, Irrgang A. Rare Plasmid-Mediated AmpC Beta-Lactamase DHA-1 Located on Easy Mobilized IS26-Related Genetic Element Detected in Escherichia coli from Livestock and Food in Germany. Microorganisms. 2024; 12(3):632. https://doi.org/10.3390/microorganisms12030632

Chicago/Turabian Style

Manfreda, Chiara, Annemarie Kaesbohrer, Silvia Schmoger, Tanja Skladnikiewicz-Ziemer, Mirjam Grobbel, and Alexandra Irrgang. 2024. "Rare Plasmid-Mediated AmpC Beta-Lactamase DHA-1 Located on Easy Mobilized IS26-Related Genetic Element Detected in Escherichia coli from Livestock and Food in Germany" Microorganisms 12, no. 3: 632. https://doi.org/10.3390/microorganisms12030632

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop